Varian

At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. Because, for cancer patients everywhere, their fight is our fight.
(1)

For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. For more information, visit http://www.varian.com.

09/10/2025

Radiotherapy doesn’t have to be intimidating. It can be fast, precise—and even tattooless.

Clinics are turning to guided treatment systems designed to improve patient comfort, streamline workflows, and enhance treatment accuracy. Innovative solutions like the Halcyon platform and IDENTIFY surface-guided motion management system are engineered to support faster treatments, more precise positioning, and tattooless workflows—reshaping the patient experience.

📍 https://bit.ly/3I25rO4 See it live at

QR700028438

09/09/2025

We are proud to announce that Varian’s Embozene microspheres have received CE Mark for Genicular Artery Embolization (G*E), marking a major milestone in advancing care for knee osteoarthritis. Embozene is the first and only embolic agent to receive CE-mark for this procedure in Europe.

For the hundreds of millions of patients worldwide dealing with knee osteoarthrosis, current treatment options often only provide temporary relief but often lead to total joint replacement surgery. G*E is a minimally invasive procedure intended to reduce inflammation and help relieve pain, providing new support for patients who have exhausted other options.

In parallel, we have also completed enrollment in the landmark GENESIS II trial, a randomized, sham-controlled study that will rigorously evaluate the safety and efficacy of G*E for knee osteoarthritis.

Learn more here https://bit.ly/G*E_CE_Mark
QR700028072

09/08/2025

We’re proud to contribute to the scientific dialogue at — driven by a shared commitment to elevating cancer care across the patient journey.

Nearly one-third of our funded abstracts earned podium recognition, reinforcing the impact of our research investments in solving what matters most:

🔹 Streamlined, patient-centered workflows
🔹 Precision and efficiency in care delivery
🔹 Scalable innovation in radiation oncology

By focusing on the toughest challenges, we unlock the greatest potential for meaningful outcomes. Because progress in cancer care isn’t just about innovation—it’s about impact. Together.

📍 Check out the abstracts, live at https://bit.ly/3I25rO4

09/07/2025

On World Radiotherapy Awareness Day, Varian is proud to be its Visionary Sponsor and join clinicians, researchers, policymakers, and industry leaders across the globe to share this message: Radiotherapy saves lives, and we must do more to make it available to all who need it.

Radiotherapy’s proven effectiveness and highly precise, personalized, and cost-effective treatment make it a cornerstone of modern treatment that benefits millions each year.

Hear what Arthur Kaindl, Head of Varian, has to say about its importance.

QR700028623

09/05/2025

RapidArc Dynamic* vs. conventional VMAT — the results are in.
Across five cases -- breast, lung, pancreas/liver, prostate, and head & neck -- the peer-reviewed study conducted by Varian shows:
✨ Superior dosimetry — reduced dose to OARs
⚡ Improved efficiency — streamlined optimization and planning
⏱️ Faster delivery — treatment times reduced by up to 25%

Highlights you’ll want to see:
🔹 Breast: Heart mean dose ↓ 1.98 → 1.23 Gy
🔹 Lung: Heart V5Gy ↓ 60.75% → 48.14%
🔹 Prostate: Better bladder & re**um sparing (V18Gy)
🔹 Head & Neck: Oral cavity ↓ ≥ 2 Gy

Read the full peer-reviewed study: Clark R, et al. Cureus
https://bit.ly/ClarkR_etal_Cureus

The results of this study were achieved in the study’s unique setting. Because there is no “typical” clinical setting and many variables exist, there is no guarantee that customers will achieve the same results.

*RapidArc Dynamic is an optional feature.
Not available for sale in all markets.

QR700027891

09/04/2025

Advances in imaging, planning, and treatment delivery are making radiotherapy more effective, tolerable, and safer than ever.

This non-invasive treatment option can preserve organ structure and function during treatment, making it an ideal choice to treat areas that are surgically inaccessible.

Learn more about the different applications of radiotherapy and join the global radiotherapy community to bring awareness to the vital importance of radiotherapy by being the celebrating World Radiotherapy Awareness Day on September 7.

09/02/2025

An important benefit of radiotherapy is the ability to precisely target a patient’s tumor while sparing nearby healthy tissue.

That this benefit is often unknown to the public is one of the reasons Varian is the proud Visionary Sponsor of World Radiotherapy Awareness Day on September 7—to educate on the effectiveness of this treatment that helps millions of people each year.

Learn more about what to expect during treatment and the science behind external beam radiation therapy.

QR700027942

08/29/2025

According to Lancet Oncology (Nov 2024), between 50% and 70% of cancer patients will benefit from radiotherapy at some point in their care.

Whether shrinking the tumor before surgery, providing much need pain relief, or precisely eliminating the tumor all together—radiotherapy can offer a range of benefits to patients with a wide range of cancer types.

As Visionary Sponsor of World Radiotherapy Awareness Day, we're dedicated to amplifying the value of this important treatment and educating patients on the science behind radiotherapy. If you or a loved one is facing a cancer diagnosis, visit our empowerME site to learn what you can expect during radiotherapy.

QR700027942

08/28/2025

Varian is proud to be the Visionary Sponsor of the inaugural World Radiotherapy Awareness Day on September 7.

Over the decades, technological advancements have made radiotherapy treatments more accurate, more efficient, and safer for healthy tissue. Yet, this important treatment technique is not available to all who could benefit.

This landmark event is raising global awareness of the critical role radiotherapy plays in cancer care and shines a spotlight on its life-saving potential. Join us in celebrating this important day and sharing your experience with radiotherapy.

QR700027942

08/28/2025

🚨 Exciting milestone in cancer care! 🎉
We’re proud to share that Novant Health is the first site in the U.S. to go live with RapidArc Dynamic,* Varian’s next-generation treatment planning and delivery solution.

RapidArc Dynamic combines precision, speed, and flexibility—aimed at helping clinicians plan and deliver high-quality treatments faster while enhancing dose sparing for critical structures.

“At Novant Health, our cause is to create a healthier future and bring remarkable experiences to life. In keeping with that commitment, we are proud to be the first in the country to be able to bring this exciting, advanced technology to our patients with the potential to increase plan quality, decrease treatment time, and increase efficiency of the planning process." — Alan Baydush, PhD DABR, Chief Physicist, Novant Health Forsyth Medical Center

We look forward to supporting Novant Health as they continue leading the way in advancing care for more patients.

The statement by Varian’s customer described here is based on results achieved in the customer’s unique clinical setting. Because there is no “typical” clinical setting and many variables exist, there is no guarantee that other customers will achieve the same results.

*RapidArc Dynamic is available as an optional feature on the Eclipse v18.1 and TrueBeam 4.1 systems.

QR700027955

08/25/2025

Varian is proud to announce the completion of enrollment and treatment in the FAST-02 clinical trial — an important step in our ongoing exploration of Flash therapy, with the potential to reduce damage to surrounding healthy tissues while maintaining effective tumor control.

“This is an exciting time for radiation oncology; completing enrollment in FAST-02 underscores our commitment to develop the evidence needed to advance technologies that have the potential to transform the future of cancer care. We are proud to collaborate with institutions that share our vision for patient-centered innovation,” said Deepak Khuntia, senior vice president and chief medical officer at Varian.

We’re grateful to the clinical investigators, research teams, and participants who contributed to this study.

Read the press release: https://bit.ly/3UKX63Z

CAUTION: The Flash-enabled ProBeam system is an investigational device and is limited by United States law for investigational use.

Address

3100 Hansen Way
Palo Alto, CA
94304

Telephone

+16504934000

Website

http://www.varian.com/

Alerts

Be the first to know and let us send you an email when Varian posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Palo Alto?

Varian

09/10/2025

09/09/2025

09/08/2025

09/07/2025

09/05/2025

09/04/2025

09/02/2025

08/29/2025

08/28/2025

08/28/2025

08/25/2025

Address

Telephone

Website

Alerts

Shortcuts

Share

Category